

SPEAKERS
PLENARY SPEAKERS

Professor Cyrille Boyer
Codirector of Australian Centre for NanoMedicine and Deputy Head of School (Research), School of Chemical Engineering
University of New South Wales, Australia
More information coming soon....

Professor João Mano
Full Professor of Biotechnology at the Chemistry Department
University of Aveiro, Portugal
João F. Mano is a Full Professor of Biotechnology at the Chemistry Department of University of Aveiro, Portugal. He combines advanced biomaterials and cells towards multidisciplinary concepts in the field of regenerative and personalized medicine. Specifically, he utilizes biomimetic and nano/micro-technology approaches to develop polymer-based biomaterials for the creation of biomedical devices with enhanced structural and multi-functional properties. He also engineers microenvironments to regulate cell behavior and organization, with the goal of clinically applying these technologies in advanced therapies or in the bioengineering of disease models. He serves as the Editor-in-Chief of Materials Today Bio (Elsevier). He has been coordinating multiple research projects, including 2 Advanced Grants, 1 Synergy Grant, and 3 Proof-of-Concept Grants from the European Research Council. He received different honours, including two honoris causa doctorates (Univ. of Lorraine and Univ. Utrecht), the George Winter Award 2020 from the ESB and he was elected fellow FEurASc, FBSE and FAIMBE.

Associate Professor Fan Yang
Associate Professor of Orthopaedic Surgery and of Bioengineering
Stanford University, USA
Fan Yang is an Associate Professor with tenure at Stanford University with joint appointments in the Departments of Bioengineering and Orthopedic Surgery. She is the founder and Director of Stanford Stem Cells and Biomaterials Engineering Laboratory, and also Co-director of Stanford NIH Biotechnology Training Program. Her research seeks to develop therapies for regenerating human tissues lost due to diseases or aging, and to build tissue engineered 3D models for understanding disease progression and informing drug discovery. Her lab invents biomaterials and engineering tools to elucidate and modulate biology, and also uses biology to inform materials and engineering design. In particular, she focus on developing hydrogels as 3D cell niche to bolster tissue regeneration through modulating how cells sense local niche mechanical properties, or inducing an immune response and crosstalk that favor a regenerative response. Prior to joining Stanford, Dr. Yang received her Ph.D. in Biomedical Engineering from Johns Hopkins University, and then completed a postdoctoral fellowship at MIT under Prof. Robert Langer. In recognition of her innovation, she has been recognized by numerous awards including Fellow of American Institute for Medical and Biological Engineering, MIT TR35 Global list honoree, National Science Foundation CAREER award, Young Investigator Award from Society for Biomaterials, Ellen Weaver Award by the Association for Women in Science, Baxter Faculty Scholar Award, the McCormick Faculty Award, and Stanford Asian American Faculty Award etc.

Professor Jean Yang
Director of the Sydney Precision Data Science Centre and an NHRMC Investigator Fellow.
University of Sydney, Australia
Professor Jean Yang is a leader in statistical bioinformatics who works in cutting-edge biomedical research. She is currently the Director of the Sydney Precision Data Science Centre and an NHRMC Investigator Fellow. Her research has led to seminal advances in the integration of multi-layered biological data by removing extraneous variability and accounting for heterogeneity. Recently, she has made similarly significant advances in scalable data integration in single-cell transcriptomics sequencing. The success of her work has enabled world-leading research into melanoma, coronary artery disease, Parkinson’s disease and kidney transplants. She was awarded the 2015 Moran Medal in statistics from the Australian Academy of Science in recognition of her work on developing methods for molecular data arising in cutting-edge biomedical research. She was elected a Senior Fellow of the Australian Bioinformatics and Computational Biology Society in 2022 and inducted as a fellow of the Royal Society of New South Wales in 2025. As a statistical data scientist who works at the interface of statistics, biomedicine, and health, she enjoys developing novel methods with translational potential in a collaborative environment, working closely with investigators from diverse backgrounds.
KEYNOTE SPEAKERS
%20Cui.png)
Professor Steven ( Xiaolin) Cui
The Chinese University of Hong Kong, Shenzhen, China
Dr. Steven (Xiaolin) Cui is an Assistant Professor of Biomedical Engineering at the School of Medicine, The Chinese University of Hong Kong, Shenzhen. His research focuses on regenerative medicine, smart biomaterials, single-atom nanozymes, and advanced biofabrication, with particular emphasis on myocardial repair and tissue regeneration. He has served as principal investigator on numerous research projects funded by the National Natural Science Foundation of China, Guangdong Province, Shenzhen Municipality, and other agencies. Dr. Cui has published more than 90 SCI-indexed papers, with representative work appearing in high impact journals such as Nature Synthesis, ACS Nano, Advanced Functional Materials, etc. He was named among the World’s Top 2% Scientists in both 2024 and 2025. During his time in New Zealand, he received the National Heart Foundation of New Zealand Research Fellowship, the Ministry of Business, Innovation and Employment (MBIE) Science Whitinga Fellowship, and the University of Otago Health Sciences Postdoctoral Fellowship. He was also honored with the WFIRM Young Investigator Award by the International Society for Biofabrication (ISBF).

Professor Shirley Jansen
Curtin University, Australia
Professor Shirley Jansen is a vascular and endovascular surgeon whose career spans clinical leadership, academic excellence, and pioneering research. She currently holds the Lawrence-Brown Chair of Vascular Surgery at Curtin University's School of Population Health and serves as Head of the Department of Vascular Surgery at Sir Charles Gairdner Hospital, a role she has held since 2015. In addition, she is the Director of the Heart & Vascular Research Institute at the Harry Perkins Institute for Medical Research. Her early career was marked by prestigious fellowships, including a British Heart Foundation Research Fellowship (1996), and multiple international travelling fellowships from leading surgical societies and industry sponsors between 2001 and 2002. Professor Jansen has over 20 years of experience treating vascular disease and has played a vital role in shaping healthcare policy, and clinical standards. She has been Site PI in over 50 clinical trials in pharma, device, first in man, RCTS and registries, many global and leading to changes in practice. She has over 170 peer-reviewed publications, including chapters in key surgical textbooks. Her research has attracted over $15 million in funding, supporting groundbreaking work in biologic therapeutics, vascular medicine, and international clinical trials. S Jansen is Co-Founder and Director of Atherid Therapeutics Pty Ltd developing a novel first in class therapeutic to remove cholesterol and lipid from the arterial wall in atherosclerosis with inventor A/Prof Juliana Hamzah, Head of Targeted Drug Delivery, Imaging and Therapeutics Lab, Harry Perkins Institute of Medical Research. S Jansen’s other main research interest is in the mechanical impacts on the vessel wall as it relates to arterial disease and intervention, and the development of 3D bioprinted vascular devices with her colleague A/Prof Elena Juan Pardo, an expert in bioengineering at the Perkins.

Dr Joanneke Maitz
ANZAC Research Institute, Concord Repatriation General Hospital, Australia
Dr. Joanneke Maitz is a surgeon and scientist in burns and reconstructive surgery with a strong focus in translational skin tissue engineering research. Dr. Maitz leads the Burns & Reconstructive Surgery Research Group at the ANZAC Research Institute of Concord Repatriation General Hospital, Sydney and is a clinical senior lecturer at the University of Sydney. Dr Maitz’s focus in translational research of clinical and laboratory-based research of bioengineering in burns and scarring burns treatment and reconstructive surgery is aimed at bridging clinical, scientific and commercial fields.

Dr Jacqui McGovern
QUT, Australia
Dr Jacqui McGovern is an interdisciplinary researcher who utilizes biomaterials and tissue engineering techniques to generate in vitro and in vivo models of bone metastatic cancers (e.g. breast and prostate cancer), as well as bone-resident tumours (osteosarcoma and multiple myeloma). She has expertise in 3D tissue models of complex organs, such as skin and bone. Her research aims to use these advanced models to study fundamental interactions between cancer cells and the human bone microenvironment, with the ultimate goal of improving the quality of life for patients affected by metastatic cancer. Dr McGovern has received support from the International Myeloma Foundation, Cancer Australia and Advance Queensland.

Professor Christophe Moser
EPFL, Switzerland
Christophe Moser graduated in physics from EPFL in 1993 and began his career as an engineer at Hexagon Metrology in Switzerland. He earned his PhD in 2000 in optical information processing from the California Institute of Technology. He co-founded and served as CEO of Ondax, Inc. in Monrovia, California, a company later acquired by Coherent. In 2010, he returned to EPFL, where he is now Full Professor. His research interests include volumetric 3D printing, ultra-compact endoscopy using multimode fibers and optical computing.Beyond his academic role, he has been instrumental in launching several ventures: Composyt Light Lab (2014, acquired by Intel in 2015) in head-worn displays, EarlySight SA (2019), Readily3D SA (2020), and Modendo (2021). He is a fellow of the Optical Society of Europe and has published over 120 peer-reviewed articles while accumulating more than 80 patents.

Professor Mikyung Shin
Sungkyunkwan University, Republic of Korea
Mikyung Shin is an Associate Professor in the Department of Biomedical Engineering at Sungkyunkwan University, South Korea. She received her Ph.D. from the Graduate School of Nanoscience and Technology at the Korea Advanced Institute of Science and Technology (KAIST) and completed her postdoctoral research in the Department of Bioengineering at the University of Pennsylvania. Her research focuses on tissue-adhesive and soft biomaterials engineering for tissue regeneration and bioelectronic interfaces. In particular, her work encompasses the development of advanced biomaterials for electroactive tissues, including central and peripheral nerves as well as cardiac and skeletal muscles, and for biotic–abiotic interfacing. Her representative research has been published in leading journals, including Nature (2023), Nature Electronics (2023, 2024), Nature Materials (2017), Nature Biomedical Engineering (2018), and Advanced Materials (2023, 2024), among others. Mikyung Shin was selected as a member of the Young Korean Academy of Science and Technology (Y-KAST) in 2024 and Asian Young Scientist Fellow in 2026 and received the Young Scientist Award (Korea Presidential Award) in 2025. Additionally, she has been worked as an Associate Editor in Materials Today Bio journal since 2024.

Professor Yin Xiao
Griffith University, Australia
Prof. Yin Xiao is a distinguished professor of dentistry, oral health, and medicine at Griffith University, an adjunct professor of medical engineering at the Queensland University of Technology, and an honorary professor at the University of Queensland. He was a dental specialist (BDSc 1986 and MDSc 1991 from Wuhan University) and started his academic career in 2000 (PhD from the University of Queensland). He is the Founder and Director of the Australia-China Centre for Tissue Engineering and Regenerative Medicine (ACCTERM), established in 2013, and the Joint Research Centre of Functional Biomaterials for Tissue and Organ Replacement. His work predominantly focuses on bone, biomaterials, stem cells, dentistry, and tissue engineering. He has authored over 400 journal papers, three books, and 23 book chapters. His H-index is 98 (GS), and his work has been cited over 31,000 times. Australian Research Magazine named him one of Australia's top 250 researchers and the field leader in Biomedical Technology. He has been awarded the 2022 Outstanding Scientist award from the TERMIS-AP Society and the World’s Top 2% Scientists award in the AD Scientific Index.

Professor Yi-Chin Toh
QUT, Australia
Yi-Chin Toh is a Professor at Queensland University of Technology and is currently the Director of the ARC Training Centre for Microphysiological System Technology (MiPSET). She completed her research training at the National University of Singapore and the Massachusetts Institute of Technology. Her research focuses on engineering microphysiological systems that mimic human biological complexity while being scalable and compatible with industry standards for routine drug testing. Her work in animal-alternative testing technologies has earned awards such as the Global 3R Award (2019) and the Lab on a Chip & Dolomite Pioneers in Miniaturisation Lectureship (2022). Prof Toh is an institutional leader who actively contributes to the scientific community and research training. She serves on the Australian Research Council College of Experts and was Director of Research Training (2024-2026) at the QUT Faculty of Engineering. She is also an associate editor of Microsystems & Nanoengineering and a member of the Scientific Advisory Committee for Lab on a Chip and AIP Biomicrofluidics.

Professor Chengtie Wu
Shanghai Institute of Ceramics,
Chinese Academy of Sciences, China
Prof. Chengtie Wu is group leader of Shanghai Institute of Ceramics, Chinese Academy of Sciences, and Director of Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, and Fellow of Biomaterials Science and Engineering (FBSE), Fellow of the Royal Society of Chemisty (FRSC), and Fellow of the Chinese Society for Biomaterials (FCSBM) as well as the Outstanding Young Scholar of NSFC. Prof. Wu’s research focuses on development of novel bioactive materials for tissue/organ repair/regeneration and treatment of major diseases. He is currently serving as the Co-Editors-in-Chief of the academic journals "Biomedical Engineering Frontier (Q1)", Associate Editor of "Journal of Inorganic Materials", and the member of editorial board of "Acta Biomaterialia" and "Bioactive Materials". Up to now, Prof. Wu has published more than 340 peer-review journal papers (H-index: 106), including Advanced Materials, Science Advances, Materials Today, Matter, National Science Review, Biomaterials, etc. He has been continuously selected as “Highly Cited Chinese Researchers” by Elsevier for 11 years. Prof. Wu has issued 105 patents, of which 60 patents were authorized and 26 patents were transferred. Prof. Wu was awarded the First Prize of Shanghai Natural Science Award (2024), Journal of Materials Chemistry Lectureship (2015), IUMRS Young Scientists Award (2022), Young Scientists of Chinese Biomaterials Society (2016), Outstanding Young Scientists of Chinese Ceramics Society (2018), and the First Prize of Science and Technology of Chinese Society of Biomaterials (2019).

Professor Rongrong Zhu
Tongji University, China
Rongrong Zhu is Deputy Director of the Division of Medicine and Life Sciences at Tongji University, a Tenure-Track Distinguished Professor and Doctoral Supervisor, and Executive Deputy Director of the Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration, Ministry of Education. Her research focuses on biomaterials and neural regeneration. She has developed AI-based systems for predicting cell fate to screen bioactive materials, constructed thoracic spinal cord organoids to promote neural functional reconstruction, and identified new targets for axonal regeneration across scar tissue. Her work also includes neural repair scaffolds that restored motor function in rhesus monkeys. She has published over 60 papers as first/corresponding author in journals including Nature Biomedical Engineering, Nature Communications, Advanced Materials, and ACS Nano, and holds 18 granted patents in China and the US. She is a recipient of the National Science Fund for Distinguished Young Scholars and multiple national and provincial research programs.